Monday, 1st October 2012
Blood Glucose Meter From Nipro Diagnostics, Inc. Achieves Recognition for Second Consecutive Year
(Fort Lauderdale, FL) – The TRUEresult® blood glucose monitoring systems from Nipro Diagnostics, Inc. – a leading manufacturer and marketer of blood glucose monitoring products and diabetes management supplies – has for the second consecutive year received a “recommended“ rating from a leading consumer publication/testing organization.
< The TRUEresult meter received an "excellent" rating for accuracy and "very good" for repeatability and convenience.
The TRUEresult® meter received an “excellent” rating for accuracy and “very good“ for repeatability and convenience. Additionally, the TRUE2go® meter rated “very good” for accuracy and repeatability, and “good” for convenience. These TRUE brand meters, co-branded by well-known national pharmacies and distributors, placed higher in the overall ratings than several well-known national brand name blood glucose meters.
Nipro Diagnostics, Inc. is highly committed to the accuracy and precision performance of our products. In terms of accuracy, recent extensive clinical testing of the TRUEresult and TRUE2go systems has proven that these systems exceed the more stringent accuracy criteria as outlined in ISO/DIS 15197 with > 99% of results within the ISO bias limits, as well as the accuracy criteria of ISO standard 15197:2003, which is the current FDA-recognized benchmark. Some other national brands have not yet confirmed that their current products to confirm that they comply with the more stringent accuracy criteria of the proposed ISO/DIS 15197 standard.
Results like these demonstrate our belief that the blood glucose monitoring systems we produce are not just equal, but even superior in performance when tested against specific national brands
“Results like these demonstrate our belief that the blood glucose monitoring systems we produce are not just equal, but even superior in performance when tested against specific national brands,” said Scott Verner, President and CEO. “Nipro Diagnostics provides products that deliver exceptional outcomes at highly affordable prices, and we’ve proven our ongoing commitment to both reducing costs for patients and lowering the overall cost of healthcare. Recognition such as this validates that we go above and beyond these objectives.”
About Nipro Diagnostics, Inc.
Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high quality blood glucose monitoring systems and ancillary products available around the world. Nipro Diagnostics is the exclusive supplier of diabetes care solutions co-branded under the TRUE name, for leading pharmacies including Walgreens, CVS, Rite Aid and Publix; as well as for distributors and mail service providers such as McKesson, Cardinal Health, AmerisourceBergen, Invacare Supply Group and Liberty Medical. For more information, please visit www.niprodiagnostics.com.